Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by IvanVanBeethovenon Apr 24, 2018 3:59pm

93 Views

Post# 27934161

RE:RE:RE:RE:Disguised

Of course, i suppose Longholder meant the annual filings. My 'Asperger' mind again ... !

7s5911 wrote: The next qurterly results should be announced in May, as Ian mentioned. We can expect year end results in the next few days. Last year, the press release was May 1. We should get some insight as to fiscal health and monthly burn rate, which may provide more insight into the need (or not) for financing.

Bullboard Posts

The top TSX healthcare stocks under $1